Cerebral Embolic Protection Devices: Current State of the Art
Transcatheter aortic valve replacement (TAVR) has become a first-line treatment for severe aortic stenosis with intermediate to high-risk population with its use increasingly expanding into younger and low-risk cohorts as well. Cerebrovascular events are one of the most serious consequential complic...
Main Authors: | Ankit Agrawal, Toshiaki Isogai, Shashank Shekhar, Samir Kapadia |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2023-03-01
|
Series: | US Cardiology Review |
Online Access: | https://www.uscjournal.com/articleindex/usc.2022.12 |
Similar Items
-
Utilization and outcomes of aortic valve replacements (from the United States readmissions database)
by: Shashank Shekhar, et al.
Published: (2022-07-01) -
Comparison of Outcomes Following Transcatheter Aortic Valve Replacement Requiring Peripheral Vascular Intervention or Alternative Access
by: Toshiaki Isogai, et al.
Published: (2023-06-01) -
Periprocedural and Short‐Term Outcomes of Percutaneous Left Atrial Appendage Closure According to Type of Atrial Fibrillation
by: Toshiaki Isogai, et al.
Published: (2021-11-01) -
The Role of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement
by: Ozan M. Demir, et al.
Published: (2018-10-01) -
Feasibility and Safety of Cerebral Embolic Protection Device Insertion in Bovine Aortic Arch Anatomy
by: Ana Paula Tagliari, et al.
Published: (2020-12-01)